The gap between the required and the available cancer care in the world widened in the last decade for the majority of cancer patients in the world. These include patients in many Low and Middle Income Countries, and increasing fractions of underserved patients in rich countries get increasing difficulties in affordability of high value cancer care. Despite international efforts, there in no indication that the shortage wouldn't be worse in the upcoming years, with the increase of cancer prevalence, the skyrocketing increase of costs of cancer treatment and the negative economic impact of the COVID-19 pandemic and post pandemic.
The Editors and experts who contributed to this book present how there is a need for global approaches and campaign for the scientific exploration of avenues to increase affordability of better value cancer treatment for millions of cancer patients in the world. They do so while considering the interests and incentives of all stakeholders in the real world, including first cancer patients everywhere, governments, professional cancer care providers, health industries, health business and economy. All would win. The scope is global. This book is just one of many efforts to spread the idea of the win-win movement.
We are catalysts, and the credit is for the doers everywhere. From that comes the term "Global Health Catalysts Win-Win Movement" that is opened for all who share our objectives, and it belongs to stakeholders and all readers. We adopt a new term: "A living book", indicating that after publication, there are opportunities for the feedback, suggestions and innovation of readers.
The book is honoured with special contribution of the late Dr. Tabaré Vázquez, immediate past president of the republic of Uruguay, A keynote by HRH Princess Dina Mired and a foreword by Sir Muir Gray.
Sprache
Illustrationen
With figures in colour and black and white
ISBN-13
978-0-7503-3075-6 (9780750330756)
Schweitzer Klassifikation
His postgraduate studies and the early years of his medical career took place at Paris, France. He serves as Chair of the Global Health Catalyst win-win initiative, and Chair of the Board of Directors at the award-winning Global Oncology University (GO-U). He is a former President of the African Organization for Research and Training in Cancer (AORTIC), and President of International Campaign for Establishment and Development of Oncology Centres (ICEDOC: www.icedoc.org). He is on the Board of founders for AfrOX-H2 (Africa -Oxford- Harvard/Hopkins), Cancer Research Consortium & ecancerforall (World Premier comprehensive cancer center in the cloud). He contributed to the World Health Organization's (WHO) cancer strategy for the new millennium, global strategy for radiotherapy and in scientific, educational, and consultancy missions for ICEDOC and the International Agency for Atomic Energy (IAEA).in Africa, Asia, and East Europe. He contributed in the advisory editorial board of many journals e.g. ecancer, Lancet Oncology, JCO Global Oncology, the World Journal of Surgical Oncology, and Cambridge Scholars Publishing, UK.
Wilfred Ngwa is Director of the Global Health Catalyst launched at Harvard in 2015 for catalyzing high impact international collaborations to reduce health disparities in the USA and globally. He is ICTU Distinguished Professor of Public Health, Associate Professor of Radiation Oncology at Johns Hopkins University and Adjunct Professor at University of Massachusetts. He is a co-founder with Prof Ahmed Elzawawy and others of the Global Oncology University (GO-U), and also founding Director of the International Phytomedicines Institute. His work at Harvard and Johns Hopkins Medicine has led to development of award-winning tiny drones to target cancer with potential to increase world-wide access to radiotherapy and immunotherapy. Dr Ngwa has won over 35 prestigious awards/honors from Harvard, the National Institutes of Health, and National and International professional societies and organizations. He chairs the Africa Health and Infrastructure Committee advising the USA government on Global Health. He has also been appointed by the Director of the USA National Institutes of Health to serve in the prestigious role of a charter member for NIH review section from 2022-2028. His has published three books on global health and serves on the editorial board for 4 leading journals including ASCO's Journal of Global Health, and Frontiers in Oncology. He serves as a chair of the Lancet Oncology Commission for Sub-Saharan Africa.
